A new Misryoum-backed poll finds about 7 in 10 Americans trust vaccine researchers as much as other scientists—amid declining vaccination rates and ongoing vaccine skepticism.
A new Misryoum review of survey results suggests vaccine researchers still benefit from a level of public trust similar to that earned by scientists overall.
Vaccine researchers’ trust level stays steady
Roughly seven in 10 Americans report a moderate or greater amount of trust that scientists working on vaccines act in the public interest.. In the poll’s numbers. 69% said they have either great or moderate trust in vaccine researchers—figures that align with how people assess medical researchers and scientists in general.
For public health experts, the key takeaway isn’t simply that trust remains high. It’s that trust and behavior can still drift apart. In the U.S., vaccination rates have faced pressure in recent years, even as attitudes toward science have not collapsed the way some headlines might suggest.
What the survey measured—and why it matters
The survey. conducted by Misryoum. used a direct question: how much. if at all. respondents trust scientists working on vaccines to act in the best interest of people like them.. The sample included 1,650 participants.. The results indicate that trust in vaccine-focused science is not meaningfully lower than trust in broader scientific work.
That matters because public communication often treats vaccine skepticism as a single problem—either “people trust science” or “they don’t.” Misryoum’s reporting framing points to a more complicated reality: people may trust researchers’ intentions while still hesitating about specific decisions. safety concerns. or recommendations.
Misryoum analysis also underscores how context shapes perception. Vaccine trust can be influenced by what people see in their communities, how they interpret risk, and whether they believe scientific institutions are listening rather than lecturing.
Outbreak pressure continues despite trust
Even with trust levels looking stable, the consequences of lower vaccination coverage are not theoretical.. Misryoum notes that vaccine-preventable diseases have continued to resurface.. Measles outbreaks have been reported across the country, and pertussis, or whooping cough, has been tied to recent deaths.
This is where the trust-behavior gap becomes urgent. High trust in researchers does not automatically produce high vaccination uptake if access barriers, local misinformation, or political signals discourage people from acting. It also doesn’t stop outbreaks from exposing gaps in coverage.
Misryoum editors see an additional tension: vaccination decisions are personal, but the impact is community-wide. When enough people delay or refuse, disease transmission accelerates, putting infants and immunocompromised individuals at particular risk.
Politics, messaging, and the “misperception” of science
Misryoum’s review highlights another insight: public concerns about science may be shifting in tone rather than in overall trust.. A frequently repeated claim during the pandemic era was that trust in science “broke.” Yet the survey suggests that’s not the full story—science remains among the most trusted institutions.
Still, communication strategies may need to adjust.. Some people associate science with unintended consequences or view scientists as distant or “superior.” Misryoum notes that vaccine scientists scored slightly better on these specific perceptions than other researchers. but the overall takeaway is clear: even trusted experts can be misunderstood.
In practical terms, trust surveys can mask what people want to hear. Many Americans may not only ask, “Do you care about the public interest?” They may also want reassurance that scientific work accounts for lived experience, uncertainty, and changing evidence—not just polished certainty.
Why the trust signal should shape future outreach
From a Misryoum perspective, these findings are a promising starting point for public health messaging.. When people already trust vaccine researchers. campaigns can focus less on restoring credibility and more on reducing friction—clarifying benefits. addressing specific concerns. and making guidance feel relevant.
That approach becomes more important as polarization continues to influence healthcare decisions. If vaccine skepticism grows louder, it can create the impression that doubts represent the majority—even when survey results suggest otherwise.
Misryoum interprets the data as a call for nuance: maintain the trust base, then work to convert trust into action. The public may be ready for that conversation, especially if outreach acknowledges why people hesitate and offers clear pathways to protect themselves and their communities.